VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CTRE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CTRECareTrust REIT, Inc.
$38.21$9.0B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
CTRE logo

CareTrust REIT, Inc.

CTRE
NYSE · Healthcare REITs
$38.21
At close - Nov 6, 4:00 PM EST - USD
Market Cap$9.03B
P/E25.3x
52W High$43.62
Volume3.18M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q2

Acquisition-Driven Growth Masks Margin Volatility Risks

CareTrust REIT is executing an aggressive acquisition-led growth strategy, with revenue surging 87.5% year-over-year to $161.3M in 2026Q2 and FFO per share up 33% to $0.51. The company maintains a healthy balance sheet with a D/E ratio of 0.27 and strong AFFO coverage of 1.37x, supporting dividend sustainability.

GrowthAccelerating
ProfitabilityStrong
ValuationExpensive
TechnicalsWeak
Explore valuation models
MARKET ACTION

CTRE price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

2/12 Beats

EPS beat 2 of last 12 quarters

02

Valuation risk

+8% Peers

P/E is 8% above peer median

03

Market leadership

RS 55 · Avg

Average momentum (RS Rating: 55)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Feb 5
01

Build the investment case

Start with the evidence for owning the stock and the risks that can break the thesis.

EXECUTIVE THESIS

The Investment Case

Full Analysis
Fundamental Trajectory

Revenue growth accelerated to 87.5% year-over-year in 2026Q2, but NOI margin volatility (99.8% vs. 56.9% in prior quarter) suggests potential accounting distortions.

Analyst Consensus+14.8% target
Buy(19 analysts)
13 Buy5 Hold1 Sell

The Bull Case

Upside Catalysts

Robust Earnings Growth

CTRE has demonstrated significant earnings growth, with a reported 157.2% year-over-year increase in earnings over the last 12 months, and a five-year average growth rate of approximately 40% per year. In Q4 2025, the company reported an EPS of $0.47, exceeding analyst expectations, and full-year 2025 net income increased by 96% over the prior year.

Favorable Market Conditions

The healthcare real estate market benefits from an aging demographic, leading to increased demand for senior care and skilled nursing facilities. There is a favorable supply/demand disconnect in this market, with similarly positioned REITs showing robust same-store NOI growth.

Strategic Portfolio Expansion

CTRE has expanded its structured finance portfolio significantly and has also expanded into the UK market, acquiring Care REIT plc, which added 135 properties and diversified its geographic footprint. The company has a substantial investment pipeline and continues to close on new investments at attractive yields.

The Bear Case

Key Downside Risks

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
CTRE+8.46%
S&P 500 (^GSPC)+7.63%
1-Year Return
CTRE+11.68%
S&P 500 (^GSPC)+9.69%
3-Year Return
CTRE+93.48%
S&P 500 (^GSPC)+73.15%
5-Year Return
CTRE+113.91%
S&P 500 (^GSPC)+60.75%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
25.3x
Forward P/EExpansion
24.6x
EV/EBITDA60th %ile
18.9x
FCF YieldCash Flow
5.5%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
25.3x
44.8x
25th· Low
EV/EBITDA
18.9x
17.8x
60th· Fair
Price/FCF
18.2x
16.5x
80th· High
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
Bear$22.13-42.1%
Base (Fair)$29.83-21.9%
Bull$37.59-1.6%
$22.13 Bear$29.83 Base$37.59 Bull
Current Market Price: $38.21
Trades at a 28.1% premium to Base DCF ($29.83)
Open DCF & Valuation Models →Chart Terminal ↗

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$477M+108.8% YoY
Net income FY25
$321M+156.3% YoY
Free cash flow FY25
$379M+60.5% YoY
Operating margin FY25
67.2%+12.8 pts YoY
ROIC (FY25)6.1%
Avg ROIC 5Y5.1%
ROE (TTM)8.1%
Piotroski Score5 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate2/12 (17%)
Revenue Beat Rate9/12 (75%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 5, 2026
$0.35-12.5%
vs $0.40
$134M+0.9%
vs $133M
Q3 2026
Aug 6, 2026
$0.38-1.0%
vs $0.38
$118M-3.3%
vs $122M
Q2 2026
May 7, 2026
$0.36+1.8%
vs $0.35
$114M+1.2%
vs $113M
Q1 2026
Feb 12, 2026
$0.47+20.5%
vs $0.39
$106M-4.0%
vs $111M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
MarketBeat·1d ago
CareTrust REIT Q3 Earnings Call Highlights

CareTrust REIT NYSE: CTRE reported 20% growth in third-quarter normalized funds from operations per share and raised the low end of its 2026 guidance, as a record pace of investment and a new U.K. care home partnership expanded its growth opportunities.

Zacks Investment Research·1d ago
5 REIT Stocks With Generous Dividends to Consider After Q3 Earnings

Here are five REIT stocks offering generous dividends that are worth considering following their favorable Q3 results this week.

Seeking Alpha·1d ago
CareTrust REIT, Inc. (CTRE) Q3 2026 Earnings Call Transcript

CareTrust REIT, Inc. ( CTRE ) Q3 2026 Earnings Call November 6, 2026 11:00 AM EST Company Participants Lauren Beale - Senior VP & Chief Accounting Officer David Sedgwick - CEO, President & Director James Callister - Chief Investment Officer & Secretary Derek Bunker - CFO & Treasurer Conference Call Participants Farrell Granath - BofA Securities, Research Division Austin Wurschmidt - KeyBanc Capital Markets Inc., Research Division Robin Haneland - BMO Capital Markets Equity Research Vikram Malhotra - Mizuho Securities USA LLC, Research Division David Rodgers - Raymond James & Associates, Inc., Research Division Michael Carroll - RBC Capital Markets, Research Division Omotayo Okusanya - Deutsche Bank AG, Research Division Michael Goldsmith - UBS Investment Bank, Research Division Michael Mueller - JPMorgan Chase & Co, Research Division Richard Anderson - Cantor Fitzgerald & Co., Research Division Alec Feygin - Robert W. Baird & Co. Incorporated, Research Division Presentation Operator Hello, everyone.

Zacks Investment Research·2d ago
CareTrust REIT (CTRE) Q3 FFO and Revenues Beat Estimates

CareTrust REIT (CTRE) came out with quarterly funds from operations (FFO) of $0.54 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to FFO of $0.45 per share a year ago.

Filtered for CareTrust REIT, Inc.More Headlines
04

Compare before deciding

Benchmark CTRE against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for CareTrust REIT, Inc. (CTRE)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CTRE logoCTRECareTrust REIT, Inc.Current
$38.21$9.03B25.30108.79%59.16%8.07%3.33%
SBRA logoSBRASabra Health Care REIT, Inc.
$21.02$5.3B76.3810.15%7.78%2.55%5.63%
LTC logoLTCLTC Properties, Inc.
$44.77$2.29B4.8225.26%127.83%37.34%5.15%
XRN logoXRNChiron Real Estate Inc.
$28.70$379.92M7.0916.34%34.26%8.88%13.62%
CHCT logoCHCTCommunity Healthcare Trust Incorporated
$14.71$420.29M17.774.67%17.8%5.34%13.58%
OHI logoOHIOmega Healthcare Investors, Inc.
$48.19$14.35B20.3113.95%57.66%13.66%5.21%

Compare CTRE vs Peers

CareTrust REIT, Inc. (CTRE) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs SBRA

Most directly comparable listed peer for CTRE.

Scale Benchmark

vs WELL

Larger-name benchmark to compare CTRE against a more recognizable public peer.

Peer Set

Compare Top 5

vs SBRA, LTC, XRN, CHCT

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

CTRE SEC Filings & Documents

CareTrust REIT, Inc. (CTRE) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 6, 2026·SEC

Material company update

May 21, 2026·SEC

Material company update

May 20, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 12, 2026·SEC

FY 2025

Feb 12, 2025·SEC

FY 2024

Feb 8, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 6, 2026·SEC

FY 2026

May 7, 2026·SEC

FY 2025

Nov 5, 2025·SEC

Get notified when CTRE posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CTRE Frequently Asked Questions

CareTrust REIT, Inc. (CTRE) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is CareTrust REIT, Inc.'s revenue?

CareTrust REIT, Inc. (CTRE) reported $615.5M in revenue over the trailing twelve months. Revenue was $476.6M in fiscal year 2025. That is 1033% more than the $42.1M of fiscal year 2012.

How fast is CareTrust REIT, Inc. growing?

CareTrust REIT, Inc. (CTRE) grew revenue by 89.9% over the trailing twelve months, compared with the twelve months before.

Is CTRE profitable?

Yes. CareTrust REIT, Inc. (CTRE) earned $364.1M in net income over the trailing twelve months (a 59.2% net margin).

Dividend & Returns
Does CTRE pay dividends?

Yes. CareTrust REIT, Inc. (CTRE) pays a dividend that yields 3.33% at the current price, a moderate yield.

What is CTRE's return on equity?

CareTrust REIT, Inc. (CTRE) had a return on equity (ROE) of 8.1% over the trailing twelve months. That is below the market's typical 10-15%.

Industry Metrics
What is CareTrust REIT, Inc.'s FFO?

CareTrust REIT, Inc. (CTRE) generated Funds From Operations (FFO) of $484.4M in the trailing twelve months. FFO is the primary profitability metric for REITs.

Is CTRE a good dividend stock?

CareTrust REIT, Inc. (CTRE) offers a 3.33% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.

What if you invested $1,000 in CTRE back in 2012?

Total return calculator · dividends reinvested · 14+ years of data

See returns →